Tomoaki Kitano
Sendagi, 1138603, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
Simultaneous detection of JAK2, CALR, and MPL mutations and quantitation of JAK2 V617F allele burden in myeloproliferative neoplasms using the quenching probe-Tm method in i-densy IS-5320.
Journal: International journal of laboratory hematology
Published: February 12, 2022
NPM1-mutation-based measurable residual disease assessment after completion of two courses of post-remission therapy is a valuable clinical predictor of the prognosis of acute myeloid leukemia.
Journal: International journal of hematology
Published: December 19, 2021
Safety and efficacy of high-dose cytarabine MEAM therapy and other treatments for auto-peripheral blood stem cell transplantation: A retrospective comparative study.
Journal: Asia-Pacific journal of clinical oncology
Published: May 02, 2021
Prognostic impact of CEBPA bZIP domain mutation in acute myeloid leukemia.
Journal: Blood advances
Published: January 18, 2021
The sensitivity of the FLT3-ITD detection method is an important consideration when diagnosing acute myeloid leukemia.
Journal: Leukemia research reports
Published: January 20, 2020
Significance of FLT3-tyrosine kinase domain mutation as a prognostic factor for acute myeloid leukemia.
Journal: International journal of hematology
Published: March 29, 2019
Importance of prognostic stratification via gene mutation analysis in elderly patients with acute myelogenous leukemia.
Journal: International journal of laboratory hematology
Published: November 25, 2018
Prognostic impact of low allelic ratio FLT3-ITD and NPM1 mutation in acute myeloid leukemia.
Journal: Blood advances
Published: April 28, 2018
Usefulness of BCOR gene mutation as a prognostic factor in acute myeloid leukemia with intermediate cytogenetic prognosis.
Journal: Genes, chromosomes & cancer
Published: December 09, 2017
Last Updated: 09/26/2026